EcoDrugPlus

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSTRUG00000027637
Gene Symbol: MIF
2 Cross references
228 Possible Orthologues:

Macrophage Migration Inhibitory Factor-Like

Ensembl ID : ENSTRUG00000028192
Gene Symbol: LOC115246418
3 Cross references
228 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSTRUG00000013975
Gene Symbol: MST1R
2 Cross references
193 Possible Orthologues:

Macrophage-Stimulating Protein Receptor

Ensembl ID : ENSTRUG00000010034
Gene Symbol: LOC101071528
2 Cross references
188 Possible Orthologues:

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSTRUG00000020749
Gene Symbol: LOC101078652
3 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 14a (Membrane-Inserted)

Ensembl ID : ENSTRUG00000008020
Gene Symbol: MMP14A
1 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSTRUG00000010165
Gene Symbol: MMP2
3 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSTRUG00000000827
Gene Symbol: MMP9
1 Cross references
215 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSTRUG00000005793
Gene Symbol: LOC101061607
3 Cross references
196 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSTRUG00000009031
Gene Symbol: MTOR
3 Cross references
216 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSTRUG00000018192
Gene Symbol: MC1R
2 Cross references
159 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSTRUG00000017775
Gene Symbol: MC4R
2 Cross references
89 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).